The Response of Patients with Superficial Bladder Cancer to a Second Course of Intravesical Bacillus Calmette-Guerin-Reference-Cited by-同舟云学术

The Response of Patients with Superficial Bladder Cancer to a Second Course of Intravesical Bacillus Calmette-Guerin

Published:1990-04 Issue:4 Volume:143 Page:710-712
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bretton P.R.¹,Herr H.W.¹,Kimmel M.¹,Whitmore W.F.¹,Laudone V.¹,Oettgen H.F.¹,Fair W.R.¹

Affiliation:

1. From the Urologic and Clinical Immunology Services, Departments of Surgery, Pathology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference13 articles.

1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976

2. Intravesical administration of bacillus Calmette-Guerin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial;Pinsky;Cancer Treat. Rep.,1985

3. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder;Herr;J. Urol.,1986

4. Bacillus Calmette-Guerin immunotherapy for blad der cancer;Lamm;J. Urol.,1985

5. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer;Catalona;J. Urol.,1987

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCG and bladder cancer. Forty-eight years after Morales report;Urologia Journal;2024-05-17

2. International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer;European Urology;2021-12

3. Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma;Therapeutic Advances in Medical Oncology;2021-01

4. Emerging intravesical therapies for the management of bacillus Calmette–Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward;Canadian Urological Association Journal;2020-01-20

5. Immunotherapy in Bladder and Renal Cancers;Cancer Immunology;2020